NDC11 71336100101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71336-1001-01 | 71336-1001 |
| 71336-1001-1 | 71336-1001 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GIVLAARI | GIVOSIRAN SODIUM | Alnylam Pharmaceuticals, Inc. | 167e663c-11e1-497b-a3fc-951d65d58eaa | 2025-09-10 | Warnings, Adverse reactions | 71336-1001-1 71336-1001 71336100101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.